Channelpedia

Nav1.5

1259 literature references associated to Nav1.5

used / unused
Pubmed id

1

364948

3

364826

5

365259

Schilling JM et al. Electrophysiology and metabolism of caveolin-3-overexpressing mice.
Basic Res. Cardiol., 2016 May , 111 (28).

9

365520

Zaklyazminskaya E et al. The role of mutations in the SCN5A gene in cardiomyopathies.
Biochim. Biophys. Acta, 2016 Jul , 1863 (1799-805).

10

365540

Sottas V et al. Negative-dominance phenomenon with genetic variants of the cardiac sodium channel Nav1.5.
Biochim. Biophys. Acta, 2016 Jul , 1863 (1791-8).

12

361465

Wang HG et al. A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias.
J. Mol. Cell. Cardiol., 2016 Jan 19 , 92 (52-62).

13

361658

18

365608

20

365061

Kubanek J et al. Ultrasound modulates ion channel currents.
Sci Rep, 2016 , 6 (24170).

23

361537

26

356252

Climent AM et al. The Role of Atrial Tissue Remodeling on Rotor Dynamics: An In-Vitro Study.
Am. J. Physiol. Heart Circ. Physiol., 2015 Sep 25 , (ajpheart.00055.2015).

27

368205

Abdelsayed M et al. Differential thermosensitivity in mixed syndrome cardiac sodium channel mutants.
J. Physiol. (Lond.), 2015 Sep 15 , 593 (4201-23).

28

362596

Neshatian L et al. Ranolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells.
Am. J. Physiol. Gastrointest. Liver Physiol., 2015 Sep 15 , 309 (G506-12).

29

366312

30

366344

Aktas CC et al. In vitro effects of phenytoin and DAPT on MDA-MB-231 breast cancer cells.
Acta Biochim. Biophys. Sin. (Shanghai), 2015 Sep , 47 (680-6).

32

356295

Musa H et al. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
Proc. Natl. Acad. Sci. U.S.A., 2015 Oct 6 , 112 (12528-33).

35

356121

36

362666

37

362554

38

368209

39

367586

Han Z et al. The effects of A-803467 on cardiac Nav1.5 channels.
Eur. J. Pharmacol., 2015 May 5 , 754 (52-60).

42

363297

Marionneau C et al. Regulation of the cardiac Na+ channel NaV1.5 by post-translational modifications.
J. Mol. Cell. Cardiol., 2015 May , 82 (36-47).

44

356896

48

348857

Ossola D et al. Force-controlled patch clamp of beating cardiac cells.
Nano Lett., 2015 Mar 11 , 15 (1743-50).

49

349082

51

356913

54

366915

Stroemlund LW et al. Gap junctions - guards of excitability.
Biochem. Soc. Trans., 2015 Jun , 43 (508-12).

60

364391

Wannous R et al. Suppression of PPARβ, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activities.
Pflugers Arch., 2015 Jun , 467 (1249-59).

61

358071

Mercier A et al. Nav1.5 channels can reach the plasma membrane through distinct N-glycosylation states.
Biochim. Biophys. Acta, 2015 Jun , 1850 (1215-23).

62

356691

Stattin EL et al. Genetic screening in sudden cardiac death in the young can save future lives.
Int. J. Legal Med., 2015 Jul 31 , ().

63

356703

Watanabe H et al. Genetics of Brugada syndrome.
J. Hum. Genet., 2015 Jul 30 , ().

65

367232

Verstraelen TE et al. The role of the SCN5A-encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders.
Neurogastroenterol. Motil., 2015 Jul , 27 (906-13).

70

348893

Saber S et al. Complex genetic background in a large family with Brugada syndrome.
Physiol Rep, 2015 Jan 1 , 3 ().

72

349473

Baruteau AE et al. Inherited progressive cardiac conduction disorders.
Curr. Opin. Cardiol., 2015 Jan , 30 (33-9).

73

358682

Wilde AA et al. Bringing home the bacon? The next step in cardiac sodium channelopathies.
J. Clin. Invest., 2015 Jan , 125 (99-101).

74

358681

Park DS et al. Genetically engineered SCN5A mutant pig hearts exhibit conduction defects and arrhythmias.
J. Clin. Invest., 2015 Jan , 125 (403-12).

76

360806

Riuró H et al. Genetic analysis, in silico prediction, and family segregation in long QT syndrome.
Eur. J. Hum. Genet., 2015 Jan , 23 (79-85).

77

349108

78

348714

79

349491

82

349202

83

361639

84

361668

Peters CH et al. Triggers for arrhythmogenesis in the Brugada and long QT 3 syndromes.
Prog. Biophys. Mol. Biol., 2015 Dec 20 , ().

86

356271

Qureshi SF et al. Mutational analysis of SCN5A gene in long QT syndrome.
Meta Gene, 2015 Dec , 6 (26-35).

88

356565

90

362758

Potet F et al. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Circ Arrhythm Electrophysiol, 2015 Aug , 8 (933-41).

94

355666

Willis BC et al. Protein Assemblies of Sodium and Inward Rectifier Potassium Channels Control Cardiac Excitability and Arrhythmogenesis.
Am. J. Physiol. Heart Circ. Physiol., 2015 Apr 10 , (ajpheart.00176.2015).

102

366441

103

363201

Han Z et al. Deletion of PDK1 causes cardiac sodium current reduction in mice.
PLoS ONE, 2015 , 10 (e0122436).

105

366203

Wang L et al. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
Cell. Physiol. Biochem., 2015 , 36 (2250-62).

107

356933

112

356323

113

350741

Mirams GR et al. Prediction of Thorough QT study results using action potential simulations based on ion channel screens.
J Pharmacol Toxicol Methods, 2014 Nov-Dec , 70 (246-54).

114

351334

Brugada R et al. Brugada syndrome.
Methodist Debakey Cardiovasc J, 2014 Jan-Mar , 10 (25-8).

115

360865

Sayeed MZ et al. Brugada syndrome with a novel missense mutation in SCN5A gene: a case report from Bangladesh.
Indian Heart J, 2014 Jan-Feb , 66 (104-7).

117

359779

118

355458

Ho GD et al. Discovery of pyrrolo-benzo-1,4-diazines as potent Na(v)1.7 sodium channel blockers.
Bioorg. Med. Chem. Lett., 2014 Sep 1 , 24 (4110-3).

119

360498

121

344657

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

122

351144

van Hoeijen DA et al. Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy.
Expert Opin Pharmacother, 2014 Sep , 15 (1875-87).

123

359887

125

350720

Shi D et al. Reduction in dynamin-2 is implicated in ischaemic cardiac arrhythmias.
J. Cell. Mol. Med., 2014 Oct , 18 (1992-9).

126

350985

127

367939

Liu M et al. Cardiac sodium channel mutations: why so many phenotypes?
Nat Rev Cardiol, 2014 Oct , 11 (607-15).

128

364486

Wang X et al. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
Pacing Clin Electrophysiol, 2014 Oct , 37 (1349-56).

130

350145

131

357761

132

349783

133

350732

Chatin B et al. Dynamitin affects cell-surface expression of voltage-gated sodium channel Nav1.5.
Biochem. J., 2014 Nov 1 , 463 (339-49).

137

360104

Ilkhanoff L et al. A common SCN5A variant is associated with PR interval and atrial fibrillation among African Americans.
J. Cardiovasc. Electrophysiol., 2014 Nov , 25 (1150-7).

139

345349

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

143

351719

144

353412

Wang Q et al. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
J. Cardiovasc. Electrophysiol., 2014 May , 25 (522-30).

147

345228

Andreasen L et al. Brugada syndrome risk loci seem protective against atrial fibrillation.
Eur. J. Hum. Genet., 2014 Mar 26 , ().

149

353109

152

352151

Elíes J et al. Inhibition of the cardiac Na⁺ channel Nav1.5 by carbon monoxide.
J. Biol. Chem., 2014 Jun 6 , 289 (16421-9).

156

344461

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

157

344483

Ben-Johny M et al. Conservation of Ca(2+)/Calmodulin Regulation across Na and Ca(2+) Channels.
Cell, 2014 Jun 19 , 157 (1657-70).

158

345110

Zhang Y et al. Measurement and interpretation of electrocardiographic QT intervals in murine hearts.
Am. J. Physiol. Heart Circ. Physiol., 2014 Jun 1 , 306 (H1553-7).

160

351993

Foadi N et al. Inhibition of voltage-gated Na⁺ channels by the synthetic cannabinoid ajulemic acid.
Anesth. Analg., 2014 Jun , 118 (1238-45).

162

352022

Alday A et al. Ionic channels underlying the ventricular action potential in zebrafish embryo.
Pharmacol. Res., 2014 Jun , 84 (26-31).

165

351953

169

351118

Hu D et al. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.
J. Am. Coll. Cardiol., 2014 Jul 8 , 64 (66-79).

170

360612

Dybkova N et al. Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa.
Cardiovasc. Res., 2014 Jul 1 , 103 (168-77).

173

352634

Glengarry JM et al. Long QT molecular autopsy in sudden infant death syndrome.
Arch. Dis. Child., 2014 Jul , 99 (635-40).

174

351205

Friedrich C et al. Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder.
EMBO Mol Med, 2014 Jul , 6 (937-51).

180

345801

Gajewiak J et al. A disulfide tether stabilizes the block of sodium channels by the conotoxin μO§-GVIIJ.
Proc. Natl. Acad. Sci. U.S.A., 2014 Feb 18 , 111 (2758-63).

181

353266

Hu D et al. ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.
Int. J. Cardiol., 2014 Feb 15 , 171 (431-42).

182

353474

185

353918

Jones JM et al. Modeling human epilepsy by TALEN targeting of mouse sodium channel Scn8a.
Genesis, 2014 Feb , 52 (141-8).

186

354788

Zhang Y et al. The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3.
Pediatr Cardiol, 2014 Feb , 35 (295-300).

187

359155

189

349776

Schroder EA et al. Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.
Am. J. Physiol. Heart Circ. Physiol., 2014 Dec 15 , 307 (H1777-85).

190

349402

191

349240

Savio-Galimberti E et al. Atrial Fibrillation and SCN5A Variants.
Card Electrophysiol Clin, 2014 Dec 1 , 6 (741-748).

192

350259

193

359654

Lodder EM et al. Integrative genomic approach identifies multiple genes involved in cardiac collagen deposition.
Circ Cardiovasc Genet, 2014 Dec , 7 (790-8).

194

350110

Huang WF et al. Role of sodium channels in the spontaneous excitability of early embryonic cardiomyocytes.
Chin J Physiol, 2014 Aug 31 , 57 (188-97).

195

350493

196

350080

197

353539

199

360939

201

360600

202

360481

Amin AS SCN5A-related dilated cardiomyopathy: what do we know?
Heart Rhythm, 2014 Aug , 11 (1454-5).

203

355483

206

345572

207

345528

Hoshi M et al. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
Circ Cardiovasc Genet, 2014 Apr 1 , 7 (123-31).

208

345301

Park DS et al. Nav-igating through a complex landscape: SCN10A and cardiac conduction.
J. Clin. Invest., 2014 Apr 1 , 124 (1460-2).

209

345006

Abriel H et al. Unexpected α-α interactions with NaV1.5 genetic variants in Brugada syndrome.
Circ Cardiovasc Genet, 2014 Apr 1 , 7 (97-9).

210

345300

van den Boogaard M et al. A common genetic variant within SCN10A modulates cardiac SCN5A expression.
J. Clin. Invest., 2014 Apr 1 , 124 (1844-52).

211

345339

Wang D et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths.
Forensic Sci. Int., 2014 Apr , 237 (90-9).

212

352136

Kruse M et al. TRPM4 channels in the cardiovascular system.
Curr Opin Pharmacol, 2014 Apr , 15 (68-73).

213

353043

214

344538

Tester DJ et al. GENETICS OF LONG QT SYNDROME.
Methodist Debakey Cardiovasc J, 2014 1 , 10 (29-33).

215

345162

219

344898

Moreau A et al. Biophysics, pathophysiology, and pharmacology of ion channel gating pores.
Front Pharmacol, 2014 , 5 (53).

223

352071

Antzelevitch C et al. The role of late I Na in development of cardiac arrhythmias.
Handb Exp Pharmacol, 2014 , 221 (137-68).

224

352070

Jones DK et al. Proton modulation of cardiac I Na: a potential arrhythmogenic trigger.
Handb Exp Pharmacol, 2014 , 221 (169-81).

227

351338

Miller D et al. Sodium channels, cardiac arrhythmia, and therapeutic strategy.
Adv. Pharmacol., 2014 , 70 (367-92).

229

353546

Zimmer T et al. Voltage-gated sodium channels in the mammalian heart.
Glob Cardiol Sci Pract, 2014 , 2014 (449-63).

230

350662

Zakliaz'minskaia EV et al. [Dilated cardiomyopathy caused by p.E446K mutation in SCN5A gene].
Kardiologiia, 2014 , 54 (92-6).

233

350355

Shimizu W Clinical and genetic diagnosis for inherited cardiac arrhythmias.
J Nippon Med Sch, 2014 , 81 (203-10).

235

355992

237

360981

Ertugrul I et al. Follow up of a family with asymptomatic compound long QT syndrome mutations.
Genet. Couns., 2014 , 25 (399-403).

241

359259

242

355521

Sumitomo N E1784K mutation in SCN5A and overlap syndrome.
Circ. J., 2014 , 78 (1839-40).

244

358698

245

364074

Gabelli SB et al. Regulation of the NaV1.5 cytoplasmic domain by calmodulin.
Nat Commun, 2014 , 5 (5126).

246

367858

248

364595

Barajas-Martinez H et al. [Genetic and molecular basis for sodium channel-mediated Brugada syndrome].
Arch Cardiol Mex, 2013 Oct-Dec , 83 (295-302).

249

341158

Partemi S et al. Analysis of the arrhythmogenic substrate in human heart failure.
Cardiovasc. Pathol., 2013 Mar-Apr , 22 (133-40).

250

342654

Hermida JS et al. Dual phenotypic transmission in Brugada syndrome.
Arch Cardiovasc Dis, 2013 Jun-Jul , 106 (366-72).

251

335392

Morissette P et al. The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (137-49).

252

335375

Elkins RC et al. Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (112-22).

255

341293

Lang F et al. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth.
Hormones (Athens), 2013 Apr-Jun , 12 (160-71).

257

348318

258

347684

Shryock JC et al. The arrhythmogenic consequences of increasing late INa in the cardiomyocyte.
Cardiovasc. Res., 2013 Sep 1 , 99 (600-11).

262

354932

Matthews GD et al. Action potential wavelength restitution predicts alternans and arrhythmia in murine Scn5a(+/-) hearts.
J. Physiol. (Lond.), 2013 Sep 1 , 591 (4167-88).

266

348269

267

347589

268

347815

Sottas V et al. Characterization of 2 genetic variants of Na(v) 1.5-arginine 689 found in patients with cardiac arrhythmias.
J. Cardiovasc. Electrophysiol., 2013 Sep , 24 (1037-46).

271

342061

Black JA et al. Noncanonical roles of voltage-gated sodium channels.
Neuron, 2013 Oct 16 , 80 (280-91).

272

342482

Sheets MF et al. Outward stabilization of the voltage sensor in domain II but not domain I speeds inactivation of voltage-gated sodium channels.
Am. J. Physiol. Heart Circ. Physiol., 2013 Oct 15 , 305 (H1213-21).

274

339514

276

339905

278

346806

279

346513

Lee YS et al. Long QT syndrome: a Korean single center study.
J. Korean Med. Sci., 2013 Oct , 28 (1454-60).

280

342217

Gao G et al. Unfolded protein response regulates cardiac sodium current in systolic human heart failure.
Circ Arrhythm Electrophysiol, 2013 Oct , 6 (1018-24).

281

347994

Hummel YM et al. Ventricular dysfunction in a family with long QT syndrome type 3.
Europace, 2013 Oct , 15 (1516-21).

284

346933

285

348202

291

347765

Aziz PF et al. Do LQTS gene single nucleotide polymorphisms alter QTc intervals at rest and during exercise stress testing?
Ann Noninvasive Electrocardiol, 2013 May , 18 (288-93).

294

336624

Kim JJ et al. Bradycardia alters Ca(2+) dynamics enhancing dispersion of repolarization and arrhythmia risk.
Am. J. Physiol. Heart Circ. Physiol., 2013 Mar 15 , 304 (H848-60).

295

340449

296

340633

Letsas KP et al. Sinus node disease in subjects with type 1 ECG pattern of Brugada syndrome.
J Cardiol, 2013 Mar , 61 (227-31).

299

335598

Panguluri SK et al. Hyperoxia-induced hypertrophy and ion channel remodeling in left ventricle.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jun , 304 (H1651-61).

300

335911

Lang F et al. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
Expert Opin Investig Drugs, 2013 Jun , 22 (701-14).

302

343978

García-Molina E et al. A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome.
Clin. Genet., 2013 Jun , 83 (530-8).

304

334879

Nilsson MF et al. Comparative effects of sodium channel blockers in short term rat whole embryo culture.
Toxicol. Appl. Pharmacol., 2013 Jul 8 , ().

307

344236

308

340030

McCormack K et al. Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 16 , 110 (E2724-32).

309

335174

Ravens U et al. Atrial selectivity of antiarrhythmic drugs.
J. Physiol. (Lond.), 2013 Jul 16 , ().

310

335463

Takanari H et al. Efficient and specific cardiac IK1 inhibition by a new pentamidine analogue.
Cardiovasc. Res., 2013 Jul 1 , 99 (203-14).

311

334914

Gillet L et al. NaV1.5 and interacting proteins in human arrhythmogenic cardiomyopathy.
Future Cardiol, 2013 Jul , 9 (467-70).

313

347948

314

347938

315

343160

316

354865

Zhang Q et al. [Desmoplakin expression silencing affects cardiac voltage-gated sodium channel Nav1.5 in HL-1 cells].
Nan Fang Yi Ke Da Xue Xue Bao, 2013 Jul , 33 (983-9).

317

334262

Schroder EA et al. The Cardiomyocyte Molecular Clock, Regulation of Scn5a and Arrhythmia Susceptibility.
Am. J. Physiol., Cell Physiol., 2013 Jan 30 , ().

319

338064

321

331114

322

330413

323

338293

Gao G et al. RBM25/LUC7L3 function in cardiac sodium channel splicing regulation of human heart failure.
Trends Cardiovasc. Med., 2013 Jan , 23 (5-8).

326

336242

328

340626

Gao G et al. SCN5A splicing variants and the possibility of predicting heart failure-associated arrhythmia.
Expert Rev Cardiovasc Ther, 2013 Feb , 11 (117-9).

330

341526

van den Boogaard M et al. From GWAS to function: Genetic variation in sodium channel gene enhancer influences electrical patterning.
Trends Cardiovasc. Med., 2013 Dec 17 , ().

331

356031

Yu JH et al. [SCN5A mutation in patients with Brugada electrocardiographic pattern induced by fever].
Zhonghua Xin Xue Guan Bing Za Zhi, 2013 Dec , 41 (1010-4).

333

354401

Wahbi K et al. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
Arch Cardiovasc Dis, 2013 Dec , 106 (635-43).

334

339438

335

339752

van Duijvenboden K et al. Gene regulatory elements of the cardiac conduction system.
Brief Funct Genomics, 2013 Aug 22 , ().

336

342709

Bradley E et al. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2013 Aug 15 , 305 (C427-35).

337

342731

338

339567

Li X et al. [A simulation study for the effect of acid concentration and temperture on sick sinus syndrome].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2013 Aug , 30 (697-703).

339

343047

340

335753

Parisi P et al. Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation.
Epilepsy Res., 2013 Aug , 105 (415-8).

343

348087

Cheng J et al. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
J. Mol. Cell. Cardiol., 2013 Aug , 61 (102-10).

344

347993

345

348150

Rhett JM et al. The perinexus: sign-post on the path to a new model of cardiac conduction?
Trends Cardiovasc. Med., 2013 Aug , 23 (222-8).

346

347211

Li A et al. Genetic biomarkers in Brugada syndrome.
Biomark Med, 2013 Aug , 7 (535-46).

348

347800

Kaufmann SG et al. Distribution and function of sodium channel subtypes in human atrial myocardium.
J. Mol. Cell. Cardiol., 2013 Aug , 61 (133-41).

350

335640

Crotti L et al. Long QT syndrome-associated mutations in intrauterine fetal death.
JAMA, 2013 Apr 10 , 309 (1473-82).

351

336450

Hu RM et al. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
Am. J. Physiol. Heart Circ. Physiol., 2013 Apr 1 , 304 (H994-H1001).

352

337461

354

343989

Black JA et al. Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Mult. Scler., 2013 Apr , 19 (532-42).

359

339952

Reingardienė D et al. Brugada-like electrocardiographic patterns induced by hyperkalemia.
Medicina (Kaunas), 2013 , 49 (148-53).

360

346461

Auerbach DS et al. Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome.
PLoS ONE, 2013 , 8 (e77843).

364

340527

369

341891

371

335922

372

335540

Hegyi B et al. Selectivity problems with drugs acting on cardiac Na⁺ and Ca²⁺ channels.
Curr. Med. Chem., 2013 , 20 (2552-71).

373

334935

374

334965

376

336796

Di Domenico M et al. Biomarker discovery by plasma proteomics in familial Brugada Syndrome.
Front. Biosci., 2013 , 18 (564-71).

379

348054

380

347110

386

341161

390

338690

391

331167

Zumhagen S et al. Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.
Herzschrittmacherther Elektrophysiol, 2012 Sep , 23 (211-9).

392

331340

Balasuriya D et al. The sigma-1 receptor binds to the Nav1.5 voltage-gated Na+ channel with 4-fold symmetry.
J. Biol. Chem., 2012 Oct 26 , 287 (37021-9).

393

331161

Mann SA et al. R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy.
J. Am. Coll. Cardiol., 2012 Oct 16 , 60 (1566-73).

395

334601

396

334535

397

338825

398

338594

399

338492

401

339080

Hong K et al. Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation.
Eur. J. Hum. Genet., 2012 Nov , 20 (1189-92).

403

334626

408

333246

Santos LF et al. [Diagnostic criteria for the Brugada syndrome: can they be improved?].
Rev Port Cardiol, 2012 May , 31 (355-62).

413

329133

Besana A et al. Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.
J. Cardiovasc. Pharmacol., 2012 Mar , 59 (249-53).

417

329591

Hardziyenka M et al. Electrophysiologic remodeling of the left ventricle in pressure overload-induced right ventricular failure.
J. Am. Coll. Cardiol., 2012 Jun 12 , 59 (2193-202).

418

338564

Catalano A et al. An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite.
Drug Metab Lett, 2012 Jun 1 , 6 (124-8).

419

333517

425

328011

Gönczi M et al. Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys., 2012 Jun , 31 (153-62).

426

329991

Ren CT et al. Cloning and expression of the two new variants of Nav1.5/SCN5A in rat brain.
Mol. Cell. Biochem., 2012 Jun , 365 (139-48).

429

328117

Yang T et al. Blocking scn10a channels in heart reduces late sodium current and is antiarrhythmic.
Circ. Res., 2012 Jul 20 , 111 (322-32).

430

328148

van den Boogaard M et al. Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer.
J. Clin. Invest., 2012 Jul 2 , 122 (2519-30).

431

332205

Arnolds DE et al. TBX5 drives Scn5a expression to regulate cardiac conduction system function.
J. Clin. Invest., 2012 Jul 2 , 122 (2509-18).

433

328041

Laurent G et al. Multifocal Ectopic Purkinje-Related Premature Contractions: A New SCN5A-Related Cardiac Channelopathy.
J. Am. Coll. Cardiol., 2012 Jul 10 , 60 (144-56).

439

333056

Lu J et al. Improving cardiac conduction with a skeletal muscle sodium channel by gene and cell therapy.
J. Cardiovasc. Pharmacol., 2012 Jul , 60 (88-99).

441

325821

Poh YC et al. Quantification of gastrointestinal sodium channelopathy.
J. Theor. Biol., 2012 Jan 21 , 293 (41-8).

442

327742

Rook MB et al. Biology of cardiac sodium channel Nav1.5 expression.
Cardiovasc. Res., 2012 Jan 1 , 93 (12-23).

446

325131

448

325744

Hallaq H et al. Activation of protein kinase C alters the intracellular distribution and mobility of cardiac Na+ channels.
Am. J. Physiol. Heart Circ. Physiol., 2012 Feb , 302 (H782-9).

449

337610

450

330728

454

332915

457

331919

Selly JB et al. [Cardiac sinus node dysfunction due to a new mutation of the SCN5A gene].
Arch Pediatr, 2012 Aug , 19 (837-41).

459

339104

Song W et al. Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.
Pediatr Cardiol, 2012 Aug , 33 (943-9).

460

332671

Hegyi B et al. Tetrodotoxin blocks L-type Ca2+ channels in canine ventricular cardiomyocytes.
Pflugers Arch., 2012 Aug , 464 (167-74).

461

334695

462

326668

463

327428

465

329035

466

330112

469

330701

Veerakul G et al. Brugada syndrome: two decades of progress.
Circ. J., 2012 , 76 (2713-22).

471

325616

Lippi G et al. Genetic and clinical aspects of Brugada syndrome: an update.
Adv Clin Chem, 2012 , 56 (197-208).

472

328519

473

338108

Nakajima T et al. KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.
Circ. J., 2012 , 76 (2763-72).

475

337063

Lazarczyk MJ et al. Selective acquired long QT syndrome (saLQTS) upon risperidone treatment.
BMC Psychiatry, 2012 , 12 (220).

479

318054

482

320893

483

320628

Vohra J Diagnosis and Management of Brugada Syndrome.
, 2011 Sep 21 , ().

484

329360

485

324173

Yao L et al. Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice.
Am. J. Physiol., Cell Physiol., 2011 Sep , 301 (C577-86).

490

324974

491

320770

Calloe K et al. Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A.
Can. J. Physiol. Pharmacol., 2011 Oct , 89 (723-36).

492

324866

493

322996

Tester DJ et al. Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.
Mayo Clin. Proc., 2011 Oct , 86 (941-7).

494

323175

Zygmunt AC et al. Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: I. Experimental analysis of the use-dependent block.
Am. J. Physiol. Heart Circ. Physiol., 2011 Oct , 301 (H1606-14).

495

324081

497

325275

Jones DK et al. Extracellular proton modulation of the cardiac voltage-gated sodium channel, Nav1.5.
Biophys. J., 2011 Nov 2 , 101 (2147-56).

498

320296

500

320676

Parvez B et al. The "missing" link in atrial fibrillation heritability.
J Electrocardiol, 2011 Nov , 44 (641-4).

501

317959

503

321990

505

322540

Postema PG et al. Sodium channelopathies: do we really understand what's going on?
J. Cardiovasc. Electrophysiol., 2011 May , 22 (590-3).

506

319066

Martin CA et al. Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model.
Am. J. Physiol. Heart Circ. Physiol., 2011 May , 300 (H1853-62).

510

318618

512

319557

Shinlapawittayatorn K et al. A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations.
Heart Rhythm, 2011 Mar , 8 (455-62).

514

323470

517

322080

Kattygnarath D et al. MOG1: a new susceptibility gene for Brugada syndrome.
Circ Cardiovasc Genet, 2011 Jun , 4 (261-8).

518

333921

519

318877

521

325891

Tveito A et al. Defining candidate drug characteristics for Long-QT (LQT3) syndrome.
Math Biosci Eng, 2011 Jul , 8 (861-73).

523

316240

528

314277

Chockalingam P et al. Fever-induced life-threatening arrhythmias in children harboring an SCN5A mutation.
Pediatrics, 2011 Jan , 127 (e239-44).

529

318659

Hofshi A et al. A combined gene and cell therapy approach for restoration of conduction.
Heart Rhythm, 2011 Jan , 8 (121-30).

531

318709

532

316395

Widmark J et al. Differential evolution of voltage-gated sodium channels in tetrapods and teleost fishes.
Mol. Biol. Evol., 2011 Jan , 28 (859-71).

533

314327

536

316984

Albesa M et al. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
Cardiovasc. Res., 2011 Feb 1 , 89 (320-8).

537

315973

538

323572

Sun LP et al. [Update on cardiac SCN5A gene mutation and dilated cardiomyopathy].
Zhonghua Xin Xue Guan Bing Za Zhi, 2011 Feb , 39 (182-4).

543

327156

Sung RK et al. QTc prolongation and family history of sudden death in a patient with desmin cardiomyopathy.
Pacing Clin Electrophysiol, 2011 Dec , 34 (e105-8).

545

326383

547

320940

548

324265

551

318056

553

320206

Jeff JM et al. SCN5A variation is associated with electrocardiographic traits in the Jackson Heart Study.
Circ Cardiovasc Genet, 2011 Apr , 4 (139-44).

554

321958

557

316746

558

316528

Zhou R et al. Whole genome network analysis of ion channels and connexins in myocardial infarction.
Cell. Physiol. Biochem., 2011 , 27 (299-304).

560

318200

Smith JG et al. Genome-wide association studies of the PR interval in African Americans.
PLoS Genet., 2011 , 7 (e1001304).

562

320405

Frolov RV et al. Inhibition of HERG potassium channels by celecoxib and its mechanism.
PLoS ONE, 2011 , 6 (e26344).

563

141934

Himmel HM et al. QTc shortening with a new investigational cancer drug: a brief case study.
J Pharmacol Toxicol Methods, 2010 Jul-Aug , 62 (72-81).

566

314963

Bokil NJ et al. Molecular genetics of long QT syndrome.
Mol. Genet. Metab., 2010 Sep , 101 (1-8).

567

141537

569

314924

Dautova Y et al. Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.
Exp. Physiol., 2010 Oct , 95 (994-1007).

570

140731

571

140716

575

322649

Kotta CM et al. Novel sodium channel SCN5A mutations in Brugada syndrome patients from Greece.
Int. J. Cardiol., 2010 Nov 5 , 145 (45-8).

579

139705

Gavrielatos G et al. Sensitivity and specificity of sodium channel blocking test in the diagnosis of Brugada syndrome.
Int. J. Cardiol., 2010 May 28 , 141 (e31-3).

582

139337

Allegue C et al. A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system.
Electrophoresis, 2010 May , 31 (1648-55).

583

138640

584

139645

Gui J et al. Mutation-specific effects of polymorphism H558R in SCN5A-related sick sinus syndrome.
J. Cardiovasc. Electrophysiol., 2010 May , 21 (564-73).

585

334150

Campuzano O et al. Genetics of Brugada syndrome.
Curr. Opin. Cardiol., 2010 May , 25 (210-5).

586

125135

Lu JT et al. Recent progress in congenital long QT syndrome.
, 2010 Mar 10 , ().

587

136769

Casini S et al. Tubulin polymerization modifies cardiac sodium channel expression and gating.
Cardiovasc. Res., 2010 Mar 1 , 85 (691-700).

589

136511

590

136555

592

137399

595

318808

598

138222

Remme CA et al. Sodium Channel (Dys)Function and Cardiac Arrhythmias.
, 2010 Jul 14 , ().

599

139883

Fabritz L et al. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
Cardiovasc. Res., 2010 Jul 1 , 87 (60-72).

600

139642

Schroeter A et al. Structure and function of splice variants of the cardiac voltage-gated sodium channel Na(v)1.5.
J. Mol. Cell. Cardiol., 2010 Jul , 49 (16-24).

601

140361

Desaphy JF et al. Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.
Br. J. Pharmacol., 2010 Jul , 160 (1521-33).

602

140561

García-Castro M et al. The spectrum of SCN5A gene mutations in Spanish Brugada syndrome patients.
Rev Esp Cardiol, 2010 Jul , 63 (856-9).

604

124699

Liu JF et al. Mutation-specific risk in two genetic forms of type 3 long QT syndrome.
Am. J. Cardiol., 2010 Jan 15 , 105 (210-3).

605

123069

607

125481

Hakim P et al. Scn3b knockout mice exhibit abnormal sino-atrial and cardiac conduction properties.
Acta Physiol (Oxf), 2010 Jan , 198 (47-59).

610

139893

Tfelt-Hansen J et al. Inherited cardiac diseases caused by mutations in the Nav1.5 sodium channel.
J. Cardiovasc. Electrophysiol., 2010 Jan , 21 (107-15).

611

136784

612

125052

Saba S et al. Effect of right ventricular versus biventricular pacing on electrical remodeling in the normal heart.
Circ Arrhythm Electrophysiol, 2010 Feb 1 , 3 (79-87).

613

123209

Pfeufer A et al. Genome-wide association study of PR interval.
Nat. Genet., 2010 Feb , 42 (153-9).

614

137833

616

136337

Nakajima T et al. Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation.
J. Mol. Cell. Cardiol., 2010 Feb , 48 (352-9).

618

334095

Xu L et al. [The cardiac sodium channel gene SCN5A mutation and dilated cardiomyopathy].
Sheng Li Ke Xue Jin Zhan, 2010 Feb , 41 (72-4).

621

314282

Hermida JS et al. Prospective evaluation of the familial prevalence of the brugada syndrome.
Am. J. Cardiol., 2010 Dec 15 , 106 (1758-62).

622

319905

Beyder A et al. Mechanosensitivity of Nav1.5, a voltage-sensitive sodium channel.
J. Physiol. (Lond.), 2010 Dec 15 , 588 (4969-85).

624

141169

Cao X et al. Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system.
Assay Drug Dev Technol, 2010 Dec , 8 (766-80).

627

317007

Amin AS et al. SCN5A mutations in atrial fibrillation.
Heart Rhythm, 2010 Dec , 7 (1870-1).

628

139379

Zhang T et al. LQTS gene LOVD database.
, 2010 Aug 31 , ().

630

140374

633

137577

Chopra SS et al. Voltage-gated sodium channels are required for heart development in zebrafish.
Circ. Res., 2010 Apr 30 , 106 (1342-50).

638

137653

Martini B To the editor--the compendium of SCN5A mutations.
Heart Rhythm, 2010 Apr , 7 (e1).

647

140897

Kotta CM et al. Cardiac ion channel gene mutations in Greek long QT syndrome patients.
J. Appl. Genet., 2010 , 51 (515-8).

648

6832

Lee HA et al. Cellular mechanism of the QT prolongation induced by sulpiride.
Int. J. Toxicol., 2009 May-Jun , 28 (207-12).

649

1950

Baines AJ et al. Protein 4.1 and the control of ion channels.
Blood Cells Mol. Dis., 2009 May-Jun , 42 (211-5).

652

131416

653

140177

655

131391

Liu M et al. Cardiac Na+ current regulation by pyridine nucleotides.
Circ. Res., 2009 Oct 9 , 105 (737-45).

656

121425

657

122662

Amin AS et al. Exercise-induced ECG changes in Brugada syndrome.
Circ Arrhythm Electrophysiol, 2009 Oct , 2 (531-9).

658

122098

Lizotte E et al. Genetic modulation of brugada syndrome by a common polymorphism.
J. Cardiovasc. Electrophysiol., 2009 Oct , 20 (1137-41).

660

124022

Valdivia CR et al. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.
Am. J. Physiol. Heart Circ. Physiol., 2009 Oct , 297 (H1446-52).

661

131322

662

123867

Amin AS et al. Cardiac sodium channelopathies.
, 2009 Nov 29 , ().

664

121201

668

1606

Ruan Y et al. Sodium channel mutations and arrhythmias.
Nat Rev Cardiol, 2009 May , 6 (337-48).

670

123219

672

3623

673

5467

Miloushev VZ et al. Solution structure of the NaV1.2 C-terminal EF-hand domain.
J. Biol. Chem., 2009 Mar 6 , 284 (6446-54).

676

1573

Aurlien D et al. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy.
, 2009 Mar , 18 (158-60).

678

1590

van Opstal JM et al. Provocation of silence.
, 2009 Mar , 11 (385-7).

681

985

Hedley PL et al. The genetic basis of Brugada syndrome: A mutation update.
Hum. Mutat., 2009 Jun 16 , ().

682

131337

Watanabe H et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation.
Circ Arrhythm Electrophysiol, 2009 Jun , 2 (268-75).

684

8177

Lacunza J et al. Heat stroke, an unusual trigger of Brugada electrocardiogram.
, 2009 Jun , 27 (634.e1-3).

685

125071

687

131791

693

131877

694

7339

Farre C et al. Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology.
Comb. Chem. High Throughput Screen., 2009 Jan , 12 (24-37).

699

9807

Saito YA et al. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy.
Am. J. Physiol. Gastrointest. Liver Physiol., 2009 Feb , 296 (G211-8).

700

315279

Gao R et al. Functional expression of voltage-gated sodium channels Nav1.5 in human breast cancer cell line MDA-MB-231.
J. Huazhong Univ. Sci. Technol. Med. Sci., 2009 Feb , 29 (64-7).

702

131338

704

124628

Shi RM et al. [Gene mutation analysis of a Chinese family of congenital long Q-T syndrome type three.]
Zhonghua Er Ke Za Zhi, 2009 Dec , 47 (926-30).

705

121981

Escárcega RO et al. The Brugada syndrome.
Acta Cardiol, 2009 Dec , 64 (795-801).

706

124155

707

131274

Probst V et al. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.
Circ Cardiovasc Genet, 2009 Dec , 2 (552-7).

708

136403

Iturralde-Torres P et al. [Genetic in long QT syndromes]
Arch Cardiol Mex, 2009 Dec , 79 Suppl 2 (26-30).

710

8910

Black JA et al. Sodium channel activity modulates multiple functions in microglia.
Glia, 2009 Aug 1 , 57 (1072-81).

711

131548

713

121356

714

123206

Sangawa M et al. Abnormal transmural repolarization process in patients with Brugada syndrome.
Heart Rhythm, 2009 Aug , 6 (1163-9).

715

120871

716

121520

Wang J et al. Analysis of four novel variants of Nav1.5/SCN5A cloned from the brain.
Neurosci. Res., 2009 Aug , 64 (339-47).

718

7551

Tfelt-Hansen J et al. [Inherited cardiac diseases caused by Nav1.5 sodium channel mutations]
Ugeskr. Laeg., 2009 Apr 6 , 171 (1261-5).

719

123818

Oliva A et al. SCN5A mutation associated with acute myocardial infarction.
Leg Med (Tokyo), 2009 Apr , 11 Suppl 1 (S206-9).

721

131721

Newton-Cheh C et al. Common variants at ten loci influence QT interval duration in the QTGEN Study.
Nat. Genet., 2009 Apr , 41 (399-406).

722

131720

Pfeufer A et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study.
Nat. Genet., 2009 Apr , 41 (407-14).

728

131431

729

124177

Kinoshita-Kikuta E et al. Zn(II)-cyclen polyacrylamide gel electrophoresis for SNP detection.
Methods Mol. Biol., 2009 , 578 (169-82).

730

2841

Hothi SS et al. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome.
Prog. Biophys. Mol. Biol., 2008 Oct-Nov , 98 (267-80).

731

1234

Hakim P et al. Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties.
Prog. Biophys. Mol. Biol., 2008 Oct-Nov , 98 (251-66).

732

590

Charpentier F et al. Mouse models of SCN5A-related cardiac arrhythmias.
Prog. Biophys. Mol. Biol., 2008 Oct-Nov , 98 (230-7).

733

3106

Zimmer T et al. SCN5A channelopathies--an update on mutations and mechanisms.
Prog. Biophys. Mol. Biol., 2008 Oct-Nov , 98 (120-36).

734

1368

Lei M et al. Genetic Na+ channelopathies and sinus node dysfunction.
Prog. Biophys. Mol. Biol., 2008 Oct-Nov , 98 (171-8).

735

3915

Wang J et al. New variants of Nav1.5/SCN5A encode Na+ channels in the brain.
J. Neurogenet., 2008 Jan-Mar , 22 (57-75).

741

3299

744

1187

Makiyama T et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation.
J. Am. Coll. Cardiol., 2008 Oct 14 , 52 (1326-34).

745

131943

746

131978

748

5055

749

8821

Otagiri T et al. Cardiac ion channel gene mutations in sudden infant death syndrome.
Pediatr. Res., 2008 Nov , 64 (482-7).

751

131964

Remme CA et al. SCN5A overlap syndromes: no end to disease complexity?
Europace, 2008 Nov , 10 (1253-5).

752

131907

755

132146

Johnson JN et al. Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.
Heart Rhythm, 2008 May , 5 (704-9).

756

121491

Yuan BB et al. [Detection of gene mutations of SCN5A in 7 patients with Brugada syndrome]
Zhonghua Xin Xue Guan Bing Za Zhi, 2008 May , 36 (404-7).

758

3047

Holland KD et al. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy.
Neurosci. Lett., 2008 Mar 5 , 433 (65-70).

762

14677

764

132325

Saint DA The cardiac persistent sodium current: an appealing therapeutic target?
Br. J. Pharmacol., 2008 Mar , 153 (1133-42).

765

16201

766

7692

Mazzone A et al. A mutation in telethonin alters Nav1.5 function.
J. Biol. Chem., 2008 Jun 13 , 283 (16537-44).

771

8062

772

149880

Crotti L et al. Gene symbol: SCN5A. Disease: Brugada syndrome.
Hum. Genet., 2008 Jun , 123 (542).

773

149877

Crotti L et al. Gene symbol: SCN5A. Disease: Brugada syndrome.
Hum. Genet., 2008 Jun , 123 (542).

774

2269

778

15201

Albert CM et al. Cardiac sodium channel gene variants and sudden cardiac death in women.
Circulation, 2008 Jan 1 , 117 (16-23).

779

16111

Shang LL et al. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II.
Am. J. Physiol., Cell Physiol., 2008 Jan , 294 (C372-9).

780

6635

Ellinor PT et al. Cardiac sodium channel mutation in atrial fibrillation.
, 2008 Jan , 5 (99-105).

785

11106

Wu L et al. Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone.
Cardiovasc. Res., 2008 Feb 1 , 77 (481-8).

790

132048

791

122449

792

966

794

132072

797

10000

Maltsev VA et al. Molecular identity of the late sodium current in adult dog cardiomyocytes identified by Nav1.5 antisense inhibition.
Am. J. Physiol. Heart Circ. Physiol., 2008 Aug , 295 (H667-76).

798

4656

799

132189

Darbar D et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation.
Circulation, 2008 Apr 15 , 117 (1927-35).

800

2045

802

94

Remme CA et al. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
Trends Cardiovasc. Med., 2008 Apr , 18 (78-87).

805

1240

Shan L et al. SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia.
Mol. Genet. Metab., 2008 Apr , 93 (468-74).

806

3451

808

7803

Crotti L et al. Congenital long QT syndrome.
, 2008 , 3 (18).

812

16659

814

7948

815

15081

Denjoy I et al. [Brugada syndrome]
, 2007 Jul-Aug , 36 (1109-16).

817

16537

820

15130

Abriel H Cardiac sodium channel Nav1.5 and its associated proteins.
Arch Mal Coeur Vaiss, 2007 Sep , 100 (787-93).

821

132407

Etheridge SP et al. Long QT syndrome in children in the era of implantable defibrillators.
J. Am. Coll. Cardiol., 2007 Oct 2 , 50 (1335-40).

822

132447

Clancy CE et al. Mutation-specific effects of lidocaine in Brugada syndrome.
Int. J. Cardiol., 2007 Oct 18 , 121 (249-52).

823

132651

824

11655

Chung SK et al. Long QT and Brugada syndrome gene mutations in New Zealand.
, 2007 Oct , 4 (1306-14).

829

16663

831

15070

833

11599

Skinner JR et al. Brugada syndrome masquerading as febrile seizures.
Pediatrics, 2007 May , 119 (e1206-11).

834

14439

Wu L et al. Induction of high STAT1 expression in transgenic mice with LQTS and heart failure.
Biochem. Biophys. Res. Commun., 2007 Jun 29 , 358 (449-54).

836

11788

Lei M et al. SCN5A and sinoatrial node pacemaker function.
Cardiovasc. Res., 2007 Jun 1 , 74 (356-65).

840

14269

Koo SH et al. Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family.
Ann. Acad. Med. Singap., 2007 Jun , 36 (394-8).

842

16805

Kiehne N et al. Mutations in the SCN5A gene: evidence for a link between long QT syndrome and sudden death?
Forensic Sci Int Genet, 2007 Jun , 1 (170-4).

845

132632

846

13941

Medeiros-Domingo A et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome.
Circulation, 2007 Jul 10 , 116 (134-42).

847

16929

Ouyang W et al. Isoform-selective effects of isoflurane on voltage-gated Na+ channels.
Anesthesiology, 2007 Jul , 107 (91-8).

849

10715

Shin DJ et al. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Life Sci., 2007 Jan 30 , 80 (716-24).

850

15605

Tian XL et al. Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.
Biochem. Biophys. Res. Commun., 2007 Jan 26 , 352 (879-83).

851

132778

Wang DW et al. Cardiac sodium channel dysfunction in sudden infant death syndrome.
Circulation, 2007 Jan 23 , 115 (368-76).

852

132779

Arnestad M et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.
Circulation, 2007 Jan 23 , 115 (361-7).

853

15252

Yong SL et al. Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes.
Biochem. Biophys. Res. Commun., 2007 Jan 12 , 352 (378-83).

856

10965

Huang X et al. [Expression and function of voltage-gated Na+ channel isoforms in rat sinoatrial node]
Nan Fang Yi Ke Da Xue Xue Bao, 2007 Jan , 27 (52-5).

858

17348

Vecchietti S et al. In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes.
Am. J. Physiol. Heart Circ. Physiol., 2007 Jan , 292 (H56-65).

859

29652

860

132786

Pfahnl AE et al. A sodium channel pore mutation causing Brugada syndrome.
Heart Rhythm, 2007 Jan , 4 (46-53).

861

132796

Chen LY et al. A common polymorphism in SCN5A is associated with lone atrial fibrillation.
Clin. Pharmacol. Ther., 2007 Jan , 81 (35-41).

862

17594

863

13039

864

13071

Priest BT et al. ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels.
Toxicon, 2007 Feb , 49 (194-201).

865

10651

Crotti L et al. Gene symbol: SCN5A.
Hum. Genet., 2007 Feb , 120 (913).

866

12685

Strege PR et al. Species dependent expression of intestinal smooth muscle mechanosensitive sodium channels.
Neurogastroenterol. Motil., 2007 Feb , 19 (135-43).

868

16621

Crotti L et al. Gene symbol: SCN5A.
Hum. Genet., 2007 Feb , 120 (911-2).

870

16268

Williams BS et al. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.
Biochemistry, 2007 Dec 18 , 46 (14693-703).

874

19330

Zaragoza MV et al. Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology.
Curr. Opin. Pediatr., 2007 Dec , 19 (619-27).

875

121389

Tian L et al. [Gene (SCN5A) mutation analysis of a Chinese family with Brugada syndrome]
Zhonghua Xin Xue Guan Bing Za Zhi, 2007 Dec , 35 (1122-5).

876

7798

Gongadze N et al. Prolong QT interval and "torsades de pointes" associated with different group of drugs.
Georgian Med News, 2007 Dec , (45-9).

879

17479

880

132611

882

12222

Zhang T et al. Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.
Biochem. Biophys. Res. Commun., 2007 Apr 6 , 355 (444-50).

883

14912

Shuraih M et al. A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents.
J. Cardiovasc. Electrophysiol., 2007 Apr , 18 (434-40).

888

18214

Alonso-Atienza F et al. Action potential alternans in LQT3 syndrome: a simulation study.
, 2007 , 2007 (640-3).

889

11357

Herbert E et al. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts.
Can. J. Physiol. Pharmacol., 2006 Aug-Sep , 84 (795-802).

890

23339

Johnson D et al. Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating.
J. Biol. Chem., 2006 Sep 8 , 281 (25875-81).

891

17454

Brette F et al. Density and sub-cellular distribution of cardiac and neuronal sodium channel isoforms in rat ventricular myocytes.
Biochem. Biophys. Res. Commun., 2006 Sep 29 , 348 (1163-6).

893

21723

Mathie A et al. Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability.
Pharmacol. Ther., 2006 Sep , 111 (567-83).

895

23452

897

15294

899

14506

Wallace CH et al. Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.
Br. J. Pharmacol., 2006 Nov , 149 (657-65).

903

22342

Laitinen-Forsblom PJ et al. SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias.
J. Cardiovasc. Electrophysiol., 2006 May , 17 (480-5).

904

27761

Makielski JC et al. Na(+) current in human ventricle: implications for sodium loading and homeostasis.
J. Cardiovasc. Electrophysiol., 2006 May , 17 Suppl 1 (S15-S20).

905

28376

Wu WK et al. Involvement of Kv1.1 and Nav1.5 in proliferation of gastric epithelial cells.
J. Cell. Physiol., 2006 May , 207 (437-44).

907

23946

908

29291

Modell SM et al. The long QT syndrome family of cardiac ion channelopathies: a HuGE review.
Genet. Med., 2006 Mar , 8 (143-55).

910

133121

911

18225

Vecchietti S et al. Computer simulation of wild-type and mutant human cardiac Na+ current.
, 2006 Mar , 44 (35-44).

912

23095

O'Reilly JP et al. Slow-inactivation induced conformational change in domain 2-segment 6 of cardiac Na+ channel.
Biochem. Biophys. Res. Commun., 2006 Jun 23 , 345 (59-66).

913

27387

Allouis M et al. 14-3-3 is a regulator of the cardiac voltage-gated sodium channel Nav1.5.
Circ. Res., 2006 Jun 23 , 98 (1538-46).

917

28601

923

133022

926

133282

927

27258

928

22707

Maltsev VA et al. A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes.
Cardiovasc. Res., 2006 Jan , 69 (116-27).

929

22803

Furuzono S et al. Inherent pacemaker function of duodenal GIST.
Eur. J. Cancer, 2006 Jan , 42 (243-8).

931

29732

Möller C et al. Effects of estradiol on cardiac ion channel currents.
Eur. J. Pharmacol., 2006 Feb 17 , 532 (44-9).

932

29243

Rosati B et al. Regional variation in mRNA transcript abundance within the ventricular wall.
J. Mol. Cell. Cardiol., 2006 Feb , 40 (295-302).

933

21132

Xiao YF et al. Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids.
Am. J. Physiol., Cell Physiol., 2006 Feb , 290 (C362-70).

935

22906

Iraqi M et al. [Long QT syndrome in children: analysis of the Lyon series]
Arch Mal Coeur Vaiss, 2006 Feb , 99 (134-40).

937

133250

939

28272

Rudy Y et al. Computational biology in the study of cardiac ion channels and cell electrophysiology.
Q. Rev. Biophys., 2006 Feb , 39 (57-116).

942

18301

946

132995

Poelzing S et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene.
Circulation, 2006 Aug 1 , 114 (368-76).

948

21339

Meregalli PG et al. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.
J. Cardiovasc. Electrophysiol., 2006 Aug , 17 (857-64).

949

26309

950

133139

Etzrodt D et al. Letter regarding article by Burke et al, "role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks".
Circulation, 2006 Apr 18 , 113 (e709; author reply e709).

951

133122

Wolf CM et al. Inherited conduction system abnormalities--one group of diseases, many genes.
J. Cardiovasc. Electrophysiol., 2006 Apr , 17 (446-55).

953

11593

954

13342

Napolitano C et al. Brugada syndrome.
, 2006 , 1 (35).

956

14960

Teener JW et al. Dysregulation of sodium channel gating in critical illness myopathy.
J. Muscle Res. Cell. Motil., 2006 , 27 (291-6).

957

21000

Viswanathan PC et al. Molecular basis of isolated cardiac conduction disease.
Handb Exp Pharmacol, 2006 , (331-47).

958

133458

959

20586

Shim SH et al. Gene sequencing in neonates and infants with the long QT syndrome.
Genet. Test., 2005 Winter , 9 (281-4).

961

133417

Darbar D et al. Unmasking of brugada syndrome by lithium.
Circulation, 2005 Sep 13 , 112 (1527-31).

962

25661

963

24626

Sarkozy A et al. Sudden cardiac death and inherited arrhythmia syndromes.
J. Cardiovasc. Electrophysiol., 2005 Sep , 16 Suppl 1 (S8-20).

964

26922

Edrich T et al. State-dependent block of human cardiac hNav1.5 sodium channels by propafenone.
J. Membr. Biol., 2005 Sep , 207 (35-43).

965

21091

Grant AO Electrophysiological basis and genetics of Brugada syndrome.
J. Cardiovasc. Electrophysiol., 2005 Sep , 16 Suppl 1 (S3-7).

967

27413

Berge KE et al. [DNA-based diagnostics of long QT syndrome]
Tidsskr. Nor. Laegeforen., 2005 Oct 20 , 125 (2783-6).

971

26494

972

28570

973

24413

976

28262

977

27691

978

29526

979

26010

Skinner JR et al. Near-miss SIDS due to Brugada syndrome.
Arch. Dis. Child., 2005 May , 90 (528-9).

980

20692

983

28656

Yokoi H et al. Double SCN5A mutation underlying asymptomatic Brugada syndrome.
, 2005 Mar , 2 (285-92).

984

24964

Auerbach H et al. [Brugada syndrome, a rare cause of syncope]
Med. Klin. (Munich), 2005 Jun 15 , 100 (361-4).

985

23206

Young KA et al. Modulation of skeletal and cardiac voltage-gated sodium channels by calmodulin.
J. Physiol. (Lond.), 2005 Jun 1 , 565 (349-70).

986

33539

Chen T et al. Reduced voltage dependence of inactivation in the SCN5A sodium channel mutation delF1617.
Am. J. Physiol. Heart Circ. Physiol., 2005 Jun , 288 (H2666-76).

988

28951

Du R et al. [Relationship between congenital long QT syndrome and Brugada syndrome gene mutation]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2005 Jun , 27 (289-94).

990

133487

991

24526

995

133644

998

23526

Abriel H et al. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins.
Trends Cardiovasc. Med., 2005 Jan , 15 (35-40).

999

133642

1000

121180

Viswanathan PC SCN5A-linked disease syndromes: complex monogenic disorders of cardiac rhythm.
Future Cardiol, 2005 Jan , 1 (29-38).

1001

35203

Aydin A et al. Single nucleotide polymorphism map of five long-QT genes.
J. Mol. Med., 2005 Feb , 83 (159-65).

1002

133633

Hwang HW et al. R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese.
J. Med. Genet., 2005 Feb , 42 (e7; author reply e8).

1003

20275

1005

133311

Frustaci A et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome.
Circulation, 2005 Dec 13 , 112 (3680-7).

1006

133312

1007

23908

1008

23970

Arbustini E et al. Gene symbol: SCN5A. Disease: Brugada syndrome.
Hum. Genet., 2005 Dec , 118 (536).

1009

21839

Head CE et al. Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice.
J. Cardiovasc. Electrophysiol., 2005 Dec , 16 (1329-40).

1011

133453

Burke A et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks.
Circulation, 2005 Aug 9 , 112 (798-802).

1012

27742

1014

22928

Tester DJ et al. Sudden infant death syndrome: how significant are the cardiac channelopathies?
Cardiovasc. Res., 2005 Aug 15 , 67 (388-96).

1015

28982

1019

20798

Strege PR et al. Effect of mibefradil on sodium and calcium currents.
Am. J. Physiol. Gastrointest. Liver Physiol., 2005 Aug , 289 (G249-53).

1020

24305

Wang SY et al. Block of inactivation-deficient cardiac Na(+) channels by acetyl-KIFMK-amide.
Biochem. Biophys. Res. Commun., 2005 Apr 8 , 329 (780-8).

1022

36528

1024

133580

Hong K et al. Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome.
J. Mol. Cell. Cardiol., 2005 Apr , 38 (555-60).

1025

133581

Makielski JC et al. Arrhythmia mutations in non-coding region of SCN5A: implications for genetic screening.
J. Mol. Cell. Cardiol., 2005 Apr , 38 (551-3).

1027

35280

Chatrath R et al. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
Pediatr Cardiol, 2004 Sep-Oct , 25 (459-65).

1030

35075

Lei M et al. Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking.
J. Physiol. (Lond.), 2004 Sep 15 , 559 (835-48).

1032

37370

Satin J et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes.
J. Physiol. (Lond.), 2004 Sep 1 , 559 (479-96).

1034

34284

Marini M et al. [Atrial standstill: a paralysis of cardiological relevance]
, 2004 Sep , 5 (681-6).

1035

39201

Kim J et al. Calmodulin mediates Ca2+ sensitivity of sodium channels.
J. Biol. Chem., 2004 Oct 22 , 279 (45004-12).

1036

33198

1037

133731

1038

39182

Ramos E et al. State-dependent trapping of flecainide in the cardiac sodium channel.
J. Physiol. (Lond.), 2004 Oct 1 , 560 (37-49).

1040

31901

1041

37101

Zehelein J et al. Identification and characterisation of a novel KCNQ1 mutation in a family with Romano-Ward syndrome.
Biochim. Biophys. Acta, 2004 Nov 5 , 1690 (185-92).

1045

39585

Chugh SS et al. Postmortem molecular screening in unexplained sudden death.
J. Am. Coll. Cardiol., 2004 May 5 , 43 (1625-9).

1048

31613

1051

133941

1054

133818

Miller TE et al. Recurrent third-trimester fetal loss and maternal mosaicism for long-QT syndrome.
Circulation, 2004 Jun 22 , 109 (3029-34).

1055

37227

Anson BD et al. Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jun , 286 (H2434-41).

1056

33433

Lian JF et al. [Long QT syndrome gene diagnosis by haplotype analysis]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2004 Jun , 21 (272-3).

1057

32573

1058

34900

Khan IA et al. Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.
Ann Noninvasive Electrocardiol, 2004 Jul , 9 (280-9).

1059

36792

1060

37750

1061

39675

Viswanathan PC et al. Inherited sodium channelopathies: a continuum of channel dysfunction.
Trends Cardiovasc. Med., 2004 Jan , 14 (28-35).

1065

133951

1066

34003

Herfst LJ et al. Trafficking and functional expression of cardiac Na+ channels.
J. Mol. Cell. Cardiol., 2004 Feb , 36 (185-93).

1068

39789

1069

37663

McNulty MM et al. State-dependent mibefradil block of Na+ channels.
Mol. Pharmacol., 2004 Dec , 66 (1652-61).

1070

33730

Van Bemmelen MX et al. Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination.
Circ. Res., 2004 Aug 6 , 95 (284-91).

1071

38363

1072

31586

Niimura H et al. Genetic analysis of Brugada syndrome in Western Japan: two novel mutations.
Circ. J., 2004 Aug , 68 (740-6).

1073

32694

Westenskow P et al. Compound mutations: a common cause of severe long-QT syndrome.
Circulation, 2004 Apr 20 , 109 (1834-41).

1074

39343

Valdivia CR et al. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Cardiovasc. Res., 2004 Apr 1 , 62 (53-62).

1078

39231

Charpentier F et al. Cardiac channelopathies: from men to mice.
Ann. Med., 2004 , 36 Suppl 1 (28-34).

1079

31334

Moric-Janiszewska E et al. Mutational screening of SCN5A linked disorders in Polish patients and their family members.
J. Appl. Genet., 2004 , 45 (383-90).

1080

39523

1081

45089

1082

43950

1084

33257

1085

35539

Cruz SL et al. Inhibition of cardiac sodium currents by toluene exposure.
Br. J. Pharmacol., 2003 Oct , 140 (653-60).

1086

39816

1088

134159

Priori SG et al. Risk stratification in the long-QT syndrome.
N. Engl. J. Med., 2003 May 8 , 348 (1866-74).

1089

42648

Clancy CE et al. Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.
Circulation, 2003 May 6 , 107 (2233-7).

1091

47019

Herfst LJ et al. Na+ channel mutation leading to loss of function and non-progressive cardiac conduction defects.
J. Mol. Cell. Cardiol., 2003 May , 35 (549-57).

1092

47533

1093

47138

Boehmer C et al. Serum and glucocorticoid inducible kinases in the regulation of the cardiac sodium channel SCN5A.
Cardiovasc. Res., 2003 Mar 15 , 57 (1079-84).

1094

46814

Groenewegen WA et al. A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.
Cardiovasc. Res., 2003 Mar 15 , 57 (1072-8).

1098

49315

Zareba W et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
J. Am. Coll. Cardiol., 2003 Jul 2 , 42 (103-9).

1099

43762

1100

44554

Ou Y et al. Syntrophin gamma 2 regulates SCN5A gating by a PDZ domain-mediated interaction.
J. Biol. Chem., 2003 Jan 17 , 278 (1915-23).

1101

44319

1102

47704

1103

42434

Gasparini M et al. Flecainide test in Brugada syndrome: a reproducible but risky tool.
, 2003 Jan , 26 (338-41).

1105

43219

Ye B et al. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation.
Physiol. Genomics, 2003 Feb 6 , 12 (187-93).

1106

41417

Probst V et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease.
J. Am. Coll. Cardiol., 2003 Feb 19 , 41 (643-52).

1107

41200

Potet F et al. Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads.
J. Cardiovasc. Electrophysiol., 2003 Feb , 14 (200-3).

1108

134244

Viswanathan PC et al. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.
J. Clin. Invest., 2003 Feb , 111 (341-6).

1110

40730

Strege PR et al. Sodium current in human intestinal interstitial cells of Cajal.
Am. J. Physiol. Gastrointest. Liver Physiol., 2003 Dec , 285 (G1111-21).

1114

47192

Napolitano C et al. Cardiac sodium channel diseases.
Clin. Chem. Lab. Med., 2003 Apr , 41 (439-44).

1115

134151

Mok NS et al. A newly characterized SCN5A mutation underlying Brugada syndrome unmasked by hyperthermia.
J. Cardiovasc. Electrophysiol., 2003 Apr , 14 (407-11).

1116

47036

1120

40245

Makita N et al. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
Circulation, 2002 Sep 3 , 106 (1269-74).

1121

48659

1122

41774

Wang GK et al. Modifications of human cardiac sodium channel gating by UVA light.
J. Membr. Biol., 2002 Sep 15 , 189 (153-65).

1123

41502

Sakabe M et al. [Brugada syndrome occurring in an identical twin: a case report]
, 2002 Sep , 40 (111-5).

1124

41440

Ou Y et al. SCN5A is expressed in human jejunal circular smooth muscle cells.
Neurogastroenterol. Motil., 2002 Oct , 14 (477-86).

1125

48677

1126

41272

1127

40018

Priori SG et al. Natural history of Brugada syndrome: insights for risk stratification and management.
Circulation, 2002 Mar 19 , 105 (1342-7).

1129

48175

Zimmer T et al. Mouse heart Na+ channels: primary structure and function of two isoforms and alternatively spliced variants.
Am. J. Physiol. Heart Circ. Physiol., 2002 Mar , 282 (H1007-17).

1131

47277

Nagatomo T et al. Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant.
Cardiovasc. Res., 2002 Jun , 54 (624-9).

1133

41830

Matsuo K et al. [Brugada syndrome]
Nippon Rinsho, 2002 Jul , 60 (1408-14).

1137

51424

Holm AN et al. Sodium current in human jejunal circular smooth muscle cells.
Gastroenterology, 2002 Jan , 122 (178-87).

1138

48746

1140

49813

Wu L et al. Localization of Nav1.5 sodium channel protein in the mouse brain.
Neuroreport, 2002 Dec 20 , 13 (2547-51).

1141

47108

1143

134392

Splawski I et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia.
Science, 2002 Aug 23 , 297 (1333-6).

1144

134417

Valdivia CR et al. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine.
Cardiovasc. Res., 2002 Aug 1 , 55 (279-89).

1145

47239

1147

134484

Papadatos GA et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.
Proc. Natl. Acad. Sci. U.S.A., 2002 Apr 30 , 99 (6210-5).

1148

49457

1149

48048

1150

43174

Vatta M et al. Novel mutations in domain I of SCN5A cause Brugada syndrome.
Mol. Genet. Metab., 2002 Apr , 75 (317-24).

1151

50308

Noebels JL Sodium channel gene expression and epilepsy.
Novartis Found. Symp., 2002 , 241 (109-20; discussion 120-3, 226-32).

1152

46591

1153

51843

Viswanathan PC et al. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Circulation, 2001 Sep 4 , 104 (1200-5).

1154

134663

Wedekind H et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death.
Circulation, 2001 Sep 4 , 104 (1158-64).

1156

50888

Perkiömäki JS et al. Heart rate variability in patients with congenital long QT syndrome.
Ann Noninvasive Electrocardiol, 2001 Oct , 6 (298-304).

1157

53075

Ackerman MJ et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.
JAMA, 2001 Nov 14 , 286 (2264-9).

1158

43916

Ko YL et al. Linkage and mutation analysis in two Taiwanese families with long QT syndrome.
J. Formos. Med. Assoc., 2001 Nov , 100 (767-71).

1160

56076

Dhar Malhotra J et al. Characterization of sodium channel alpha- and beta-subunits in rat and mouse cardiac myocytes.
Circulation, 2001 Mar 6 , 103 (1303-10).

1161

53522

Grant AO Molecular biology of sodium channels and their role in cardiac arrhythmias.
Am. J. Med., 2001 Mar , 110 (296-305).

1162

50687

1163

51070

1164

134715

Towbin JA Ventricular tachycardia or conduction disease: what is the mechanism of death associated with SCN5A?
J. Cardiovasc. Electrophysiol., 2001 Jun , 12 (637-8).

1165

58921

1166

57640

Bajanowski T et al. Prolonged QT interval and sudden infant death--report of two cases.
Forensic Sci. Int., 2001 Jan 1 , 115 (147-53).

1167

59859

Wan X et al. Accelerated inactivation in a mutant Na(+) channel associated with idiopathic ventricular fibrillation.
Am. J. Physiol. Heart Circ. Physiol., 2001 Jan , 280 (H354-60).

1168

52011

Tan HL et al. A sodium-channel mutation causes isolated cardiac conduction disease.
Nature, 2001 Feb 22 , 409 (1043-7).

1169

55686

Mantegazza M et al. Role of the C-terminal domain in inactivation of brain and cardiac sodium channels.
Proc. Natl. Acad. Sci. U.S.A., 2001 Dec 18 , 98 (15348-53).

1171

59199

1175

51046

1176

54861

Balser JR The cardiac sodium channel: gating function and molecular pharmacology.
J. Mol. Cell. Cardiol., 2001 Apr , 33 (599-613).

1177

50180

Towbin JA et al. Genotype and severity of long QT syndrome.
Drug Metab. Dispos., 2001 Apr , 29 (574-9).

1180

57780

Li H et al. Current concepts in long QT syndrome.
Pediatr Cardiol, 2000 Nov-Dec , 21 (542-50).

1181

53432

1182

58533

Georgijević Milić L [Molecular genetics in the hereditary form of long QT syndrome]
Med. Pregl., 2000 Jan-Feb , 53 (51-4).

1183

53038

Wang DW et al. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
Circ. Res., 2000 Oct 13 , 87 (E37-43).

1185

52462

Chen SM et al. Brugada syndrome without mutation of the cardiac sodium channel gene in a Taiwanese patient.
J. Formos. Med. Assoc., 2000 Nov , 99 (860-2).

1186

63419

Veldkamp MW et al. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.
Circ. Res., 2000 May 12 , 86 (E91-7).

1189

58207

Bennett PB Long QT syndrome: biophysical and pharmacologic mechanisms in LQT3.
J. Cardiovasc. Electrophysiol., 2000 Jul , 11 (819-22).

1192

52540

1193

57729

Baroudi G et al. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.
FEBS Lett., 2000 Dec 29 , 487 (224-8).

1194

134827

1195

55515

Priori SG et al. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge.
Circulation, 2000 Aug 29 , 102 (945-7).

1196

53764

1199

62002

1200

55910

Leenhardt A et al. [Present concepts of congenital long QT syndrome]
Arch Mal Coeur Vaiss, 2000 Apr , 93 (17-21).

1201

68043

Kambouris NG et al. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
J. Clin. Invest., 2000 Apr , 105 (1133-40).

1203

54292

Antzelevitch C et al. Cellular and ionic mechanisms responsible for the Brugada syndrome.
, 2000 , 33 Suppl (33-9).

1204

61984

Bezzina C et al. A single Na(+) channel mutation causing both long-QT and Brugada syndromes.
Circ. Res., 1999 Dec 3-17 , 85 (1206-13).

1205

69399

Schott JJ et al. Cardiac conduction defects associate with mutations in SCN5A.
Nat. Genet., 1999 Sep , 23 (20-1).

1206

60260

1208

68471

Sepp R et al. [Molecular genetics of the long QT syndrome: clinical aspects]
, 1999 Nov 21 , 140 (2633-8).

1210

69708

1211

64759

Chen Q et al. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome.
Circulation, 1999 Mar 16 , 99 (1344-7).

1213

62430

Hartmann HA et al. Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain.
Nat. Neurosci., 1999 Jul , 2 (593-5).

1214

60581

Gussak I et al. The Brugada syndrome: clinical, electrophysiologic and genetic aspects.
J. Am. Coll. Cardiol., 1999 Jan , 33 (5-15).

1217

69060

Schulze-Bahr E et al. The LQT syndromes--current status of molecular mechanisms.
, 1999 Apr , 88 (245-54).

1219

68497

1220

62036

Janse MJ et al. Molecular mechanisms of arrhythmias.
, 1998 Oct , 17 Suppl 2 (II41-6).

1221

72144

1222

79984

Ackerman MJ The long QT syndrome: ion channel diseases of the heart.
Mayo Clin. Proc., 1998 Mar , 73 (250-69).

1223

79485

Kanters JK et al. Novel donor splice site mutation in the KVLQT1 gene is associated with long QT syndrome.
J. Cardiovasc. Electrophysiol., 1998 Jun , 9 (620-4).

1225

66706

Splawski I et al. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1.
Genomics, 1998 Jul 1 , 51 (86-97).

1227

72415

1229

74649

Wang Q et al. Genetics, molecular mechanisms and management of long QT syndrome.
Ann. Med., 1998 Feb , 30 (58-65).

1230

64995

Wattanasirichaigoon D et al. Molecular genetics of long-QT syndrome.
Curr. Opin. Pediatr., 1998 Dec , 10 (628-34).

1231

135392

Li H et al. New mutations in the KVLQT1 potassium channel that cause long-QT syndrome.
Circulation, 1998 Apr 7 , 97 (1264-9).

1236

71648

1237

79360

van den Berg MH et al. The long QT syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene.
Hum. Genet., 1997 Sep , 100 (356-61).

1238

74688

1239

77373

Wang Q et al. Molecular genetics of long QT syndrome from genes to patients.
Curr. Opin. Cardiol., 1997 May , 12 (310-20).

1240

71734

Le Marec H et al. [Congenital long QT syndromes]
Arch Mal Coeur Vaiss, 1997 Jun , 90 Spec No 3 (25-35).

1242

77300

Tanaka T et al. Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome.
Circulation, 1997 Feb 4 , 95 (565-7).

1243

74507

Priori SG et al. Molecular biology of the long QT syndrome: impact on management.
, 1997 Aug , 20 (2052-7).

1246

71886

Wang DW et al. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
Proc. Natl. Acad. Sci. U.S.A., 1996 Nov 12 , 93 (13200-5).

1247

82746

1248

83440

Nakajima T et al. [Long QT syndrome]
Nippon Rinsho, 1996 Mar , 54 (776-81).

1250

87576

Russell MW et al. The molecular genetics of the congenital long QT syndromes.
Curr. Opin. Cardiol., 1996 Jan , 11 (45-51).

1251

88298

Lazzara R Mechanisms and management of congenital and acquired long QT syndromes.
Arch Mal Coeur Vaiss, 1996 Feb , 89 Spec No 1 (51-5).

1252

87105

1253

135664

Moss AJ et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome.
Circulation, 1995 Nov 15 , 92 (2929-34).

1254

83345

Roden DM et al. Recent advances in understanding the molecular mechanisms of the long QT syndrome.
J. Cardiovasc. Electrophysiol., 1995 Nov , 6 (1023-31).

1255

88465

1258

135688

Bennett PB et al. Molecular mechanism for an inherited cardiac arrhythmia.
Nature, 1995 Aug 24 , 376 (683-5).